Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Recursion describes itself as a clinical stage TechBio company that uses its proprietary Recursion OS platform to analyze biological and chemical datasets. The company operates laboratories capable of ...

In this exclusive webcast, Concentrix’s Ryan Peterson, Everest Group’s Shirley Hung, and Valmont’s Heidi Hough discuss turning AI ambitions into operational advantages.

Duplicates of crystal structures are flooding databases, implicating repositories hosting organic, inorganic, and ...

Republican lawmakers decry Intel's testing of Chinese-linked tools after Reuters report Republican lawmakers accused Intel this week of threatening U.S. national security after Reuters revealed the ...

Discover how the Irrelevance Proposition Theorem explains debt's impact in corporate finance, its origin by Nobel-winning economists, and insights into its real-world applications.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...